arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

USANA HEALTH SCIENCES INC

USNA
$13.91 ▼ -0.43 (-3.00%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
18 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
56
Health
Fair
Neutral
auto_awesome

Analytical Summary

USANA HEALTH SCIENCES INC shows mixed fundamentals. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $257.8M
Dividend Yield —
Revenue Growth 8.3% ↗
Op. Margin 4.0% ↘
ROIC 1.9% ↘
FCF / Share $0.46 ↘
Trailing P/E 24.0x
Price / Book 0.5x
FCF Yield 3.3%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$925.26M
↑ +8.3% —
Net Income Profit after all expenses
$10.76M
↓ -74.4% —
Operating Margin Operating profit as % of sales
4.0%
↓ -47.9% 40th
FCF / Share Free cash flow per share
$0.46
↓ -82.7% —

Health Breakdown

Profitability ↓
34
Returns ↓
48
Financial Health ↓
94
Cash Quality ↓
53

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 68 quarters